Key facts
- It has raised $380K; the latest was Early Stage VC ($380K) in Aug 2025.
- Notable investors include Estonian Business and Innovation Agency, Michele Battistin, Nordic Science Investments, Peaksjah.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for MuRayTech
- ·The full record, as it builds
Funding rounds
No funding rounds for MuRayTech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MuRayTech
Developer of laser plasma accelerator technology designed to generate artificial muon radiation for advanced X-ray imaging in industrial and medical applications. The company's platform provides penetrative imaging capabilities and chemical element analysis through muon radiation, creating new opportunities for defense, aerospace, and car industries by offering more penetrative diagnostics for production and MRO, enabling safer medical imaging for sensitive patient groups and early cancer diagnosis through chemical composition identification.
- Sector
- Healthcare
- HQ
- Tallinn, Estonia
- Founded
- 2025
- Website
- mu-ray.tech/
- Ownership
- Privately Held (backing)
MuRayTech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MuRayTech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MuRayTech in its N-PORT filings yet. We sweep new filings monthly.